OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!
If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.
Requested Article:
PI3K PROTAC overcomes the lapatinib resistance in PIK3CA-mutant HER2 positive breast cancer
Hongyan Zhang, Longlong Zhang, Yuna He, et al.
Cancer Letters (2024) Vol. 598, pp. 217112-217112
Closed Access | Times Cited: 7
Hongyan Zhang, Longlong Zhang, Yuna He, et al.
Cancer Letters (2024) Vol. 598, pp. 217112-217112
Closed Access | Times Cited: 7
Showing 7 citing articles:
An update on promising and emerging protein kinase B/AKT inhibitors for breast cancer
Riccardo Asnaghi, Gabriele Antonarelli, Elena Battaiotto, et al.
Expert Opinion on Pharmacotherapy (2025)
Open Access | Times Cited: 1
Riccardo Asnaghi, Gabriele Antonarelli, Elena Battaiotto, et al.
Expert Opinion on Pharmacotherapy (2025)
Open Access | Times Cited: 1
The Biological Roles and Clinical Applications of the PI3K/AKT Pathway in Targeted Therapy Resistance in HER2-Positive Breast Cancer: A Comprehensive Review
Hanyi Zhong, Ziling Zhou, Han Wang, et al.
International Journal of Molecular Sciences (2024) Vol. 25, Iss. 24, pp. 13376-13376
Open Access | Times Cited: 4
Hanyi Zhong, Ziling Zhou, Han Wang, et al.
International Journal of Molecular Sciences (2024) Vol. 25, Iss. 24, pp. 13376-13376
Open Access | Times Cited: 4
Recent advances in targeted degradation in the RAS pathway
Zhiming Ge, Zisheng Fan, Wei He, et al.
Future Medicinal Chemistry (2025), pp. 1-16
Closed Access
Zhiming Ge, Zisheng Fan, Wei He, et al.
Future Medicinal Chemistry (2025), pp. 1-16
Closed Access
HER2-positive gastric cancer: from targeted therapy to CAR-T cell therapy
Qiang Shao, Junge Deng, Haoran Wu, et al.
Frontiers in Immunology (2025) Vol. 16
Open Access
Qiang Shao, Junge Deng, Haoran Wu, et al.
Frontiers in Immunology (2025) Vol. 16
Open Access
Navigating the future of gastric cancer treatment: a review on the impact of antibody-drug conjugates
Qian-Qing Yin, Yanlong Zhang, Xueqing Xie, et al.
Cell Death Discovery (2025) Vol. 11, Iss. 1
Open Access
Qian-Qing Yin, Yanlong Zhang, Xueqing Xie, et al.
Cell Death Discovery (2025) Vol. 11, Iss. 1
Open Access
Anticancer Potential of Prebiotics: Targeting Estrogen Receptors and PI3K/AKT/mTOR in Breast Cancer
Hussein Sabit, Sama Abouelnour, Bassel M. Hassen, et al.
Biomedicines (2025) Vol. 13, Iss. 4, pp. 990-990
Open Access
Hussein Sabit, Sama Abouelnour, Bassel M. Hassen, et al.
Biomedicines (2025) Vol. 13, Iss. 4, pp. 990-990
Open Access
CEA-Induced PI3K/AKT Pathway Activation through the Binding of CEA to KRT1 Contributes to Oxaliplatin Resistance in Gastric Cancer
Yifan Chen, Yulong Mi, Song Tan, et al.
Drug Resistance Updates (2024) Vol. 78, pp. 101179-101179
Closed Access | Times Cited: 2
Yifan Chen, Yulong Mi, Song Tan, et al.
Drug Resistance Updates (2024) Vol. 78, pp. 101179-101179
Closed Access | Times Cited: 2
